Rehabilitation and Survivorship Considerations in Head and Neck Cancer
Dr. Ron Karni shares best practices for assessing, diagnosing and treating head and neck lymphedema (HNL) using case studies and recent clinical data.
- Pre-rehabilitation and rehabilitation are increasingly emphasized in cancer care.
- Lymphedema is the cardinal side effect of HN cancer treatment.
- Flexitouch is the only FDA-approved device for managing HNL.
Click the timestamps below to jump to video segments on YouTube:
0:00 – Intro and agenda
4:17 – Trends and prevalence of head and neck cancer
7:43 – Side effects of cancer treatment and Dr. Karni’s treatment team
14:20 – Multi-disciplinary post treatment team
19:45 – The importance of prehabilitation, rehabilitation and lymphedema therapy
25:14 – Dr. Karni’s five key contentions about head and neck lymphedema
32:44 – How do we measure head and neck lymphedema?
38:30 – A closer look at internal lymphedema and internal imaging of the lymphatics
45:25 – Treatment options for head and neck lymphedema; the Flexitouch® Plus system
46:41 – The benefits of manual lymph drainage and how Flexitouch Plus facilitates daily treatment for patients
50:36 – Clinical data and patient results after using the Flexitouch Plus
55:50 – Summary and Q&A